Multiple Manufacturers

SIVEXTRO

Manufacturer:

Multiple Manufacturers

Sivextro HCPCS:

J3090

HCPCS Code Descriptor:

Injection, tedizolid phosphate, 1 mg

Category:

J Code

Sivextro NDCs:

67919-0040-02, 72000-0320-10

Primary Type:

Antibiotic

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

67919-0040-02, 72000-0320-10

About Sivextro:

SIVEXTRO is a medication manufactured by multiple manufacturers and aligned to the J Code: J3090. SIVEXTRO is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J3090 Added Date:

January 1, 2016

J3090 Effective Date:

January 1, 2016

J3090 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Sivextro billing and coding information.
Sivextro patient assistance information can be found through AccessSIVEXTRO at the URL: https://qa-ncoa-forms.s3.amazonaws.com/access_sivextro_pap.pdf
Our team is still working to identify a prescribing information source for SIVEXTRO
Our team has not yet identified a source of side effects information for SIVEXTRO. Please check back in a few weeks.